Astera Labs (NASDAQ:ALAB) Shares Gap Up After Analyst Upgrade

Shares of Astera Labs, Inc. (NASDAQ:ALAB) gapped up prior to trading on Wednesday after Zacks Research upgraded the stock from a hold rating to a strong-buy rating. The stock had previously closed at $311.99, but opened at $334.49. Astera Labs shares last traded at $331.49, with a volume of 1,007,863 shares changing hands.

ALAB has been the subject of several other reports. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. JPMorgan Chase & Co. boosted their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen dropped their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. Finally, Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $325.25.

Insider Transactions at Astera Labs

In related news, General Counsel Philip Mazzara sold 14,076 shares of Astera Labs stock in a transaction on Monday, May 18th. The stock was sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the completion of the sale, the general counsel owned 104,139 shares of the company’s stock, valued at approximately $24,137,337.42. This trade represents a 11.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,256,894 shares of company stock worth $362,763,135. 10.40% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the stock. Reflection Asset Management bought a new position in Astera Labs in the fourth quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the second quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs in the 4th quarter valued at about $33,000. Finally, Whipplewood Advisors LLC grew its stake in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Up 1.2%

The company’s 50 day moving average is $357.91 and its 200-day moving average is $239.63. The firm has a market capitalization of $56.00 billion, a price-to-earnings ratio of 159.79 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the company earned $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.